Clomiphene citrate for men with hypogonadism: a systematic review and meta‐analysis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: Male hypogonadism is a clinical and biochemical androgen insufficiency syndrome, becoming more prevalent with age. Exogenous testosterone is first‐choice therapy, with several side effects, including negative feedback of the hypothalamic–pituitary–gonadal axis, resulting in suppression of intratesticular testosterone production and spermatogenesis. To preserve these testicular functions while treating male hypogonadism, clomiphene citrate is used as off‐label therapy. This systematic review and meta‐analysis aimed to evaluate the effectiveness and safety of clomiphene citrate therapy for men with hypogonadism. Methods: The EMBASE, PubMed, Cochrane databases were searched in May 2021, for effectiveness studies of men with hypogonadism treated with clomiphene citrate. Both intervention and observational studies were included. The Effective Public Health Practice Project Quality Assessment Tool, a validated instrument, was used to assess methodological study quality. The primary outcome measure was the evaluation of serum hormone concentration. Secondary outcomes were symptoms of hypogonadism, metabolic and lipid profile, side effects, safety aspects. Results: We included 19 studies, comprising four randomized controlled trials and 15 observational studies, resulting in 1642 patients. Seventeen studies were included in the meta‐analysis, with a total of 1279 patients. Therapy and follow‐up duration varied between one and a half and 52 months. Total testosterone increased with 2.60 (95% CI 1.82–3.38) during clomiphene citrate treatment. An increase was also seen in free testosterone, luteinizing hormone, follicle stimulating hormone, sex hormone‐binding globulin and estradiol. Different symptom scoring methods were used in the included studies. The most frequently used instrument was the Androgen Deficiency in Aging Males questionnaire, whose improved during treatment. Reported side effects were only prevalent in less than 10% of the study populations and no serious adverse events were reported. Conclusion: Clomiphene citrate is an effective therapy for improving both biochemical as well as clinical symptoms of males suffering from hypogonadism. Clomiphene citrate has few reported side effects and good safety aspects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Thomas, B. H., Ciliska, D., Dobbins, M., & Micucci, S. (2004) · Worldviews on Evidence-Based Nursing · doi:10.1111/j.1524-475x.2004.04006.x · Cited by 2,118
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Armijo‐Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01516.x · Cited by 1,539 · cited 1×
“05 Mazzola (2014) CC= 76 29 (31) 42 (20)**BA 6.”
Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study
Bojesen, A., Juul, S., & Gravholt, C. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021491 · Cited by 894
Evaluation and Management of Testosterone Deficiency: AUA Guideline
Mulhall, J. P., Trost, L. W., Brannigan, R. E., Kurtz, E. G., Redmon, J. B., Chiles, K. A., Lightner, D. J., Miner, M. M., Murad, M. H., Nelson, C. J., et al. (2018) · Journal of Urology · doi:10.1016/j.juro.2018.03.115 · Cited by 766
Prevalence of Symptomatic Androgen Deficiency in Men
Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1245 · Cited by 720
Validation of a screening questionnaire for androgen deficiency in aging males
Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M. (2000) · Metabolism · doi:10.1053/meta.2000.8625 · Cited by 662
Criteria for the systematic review of health promotion and public health interventions
Jackson, N., & Waters, E. (2005) · Health Promotion International · doi:10.1093/heapro/dai022 · Cited by 572 · cited 1×
“2 years 42 (13) (n= 37) 3 years 50 (30) (n= 29) p< 0.”
Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J. ‐., Lunenfeld, B., Morales, A., et al. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006486 · Cited by 445
Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up
Gagnon, D. R., Zhang, T.-J., Brand, F. N., & Kannel, W. B. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90679-3 · Cited by 376
Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J.-J., Lunenfeld, B., Morales, A., et al. (2009) · European Urology · doi:10.1016/j.eururo.2008.08.033 · Cited by 345
TENOVER, J. S., MATSUMOTO, A. M., PLYMATE, S. R., & BREMNER, W. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1118 · Cited by 256
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232 · cited 1×
“Moskovic (2012) CC= 46 37 (16) 1 year 48 (22) (n= 46) n.”
Factors affecting spermatogenesis upon gonadotropin-replacement therapy: A meta-analytic study
Rastrelli, G., Corona, G., Mannucci, E., & Maggi, M. (2014) · Andrology · doi:10.1111/andr.262 · Cited by 211 · cited 1×
“05 Mazzola (2014) CC= 76 29 (31) 42 (20)**BA 6.”
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.009 · Cited by 177
Zarotsky, V., Huang, M. ‐., Carman, W., Morgentaler, A., Singhal, P. K., Coffin, D., & Jones, T. H. (2014) · Andrology · doi:10.1111/andr.274 · Cited by 176
Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample
Hall, S. A., Esche, G. R., Araujo, A. B., Travison, T. G., Clark, R. V., Williams, R. E., & McKinlay, J. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0021 · Cited by 167
Guay, A. T., Bansal, S., & Heatley, G. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530597 · Cited by 162
Risks and benefits of testosterone therapy in older men
Spitzer, M., Huang, G., Basaria, S., Travison, T. G., & Bhasin, S. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.73 · Cited by 154
Outcomes of clomiphene citrate treatment in young hypogonadal men
Katz, D. J., Nabulsi, O., Tal, R., & Mulhall, J. P. (2012) · BJU International · doi:10.1111/j.1464-410x.2011.10702.x · Cited by 142
Clomiphene citrate is safe and effective for long‐term management of hypogonadism
Moskovic, D. J., Katz, D. J., Akhavan, A., Park, K., & Mulhall, J. P. (2012) · BJU International · doi:10.1111/j.1464-410x.2012.10968.x · Cited by 136 · cited 1×
“…confirmed that there was little overlap in the study populations of Patel et al. (2015) and Keihani et al. (2020), and between Katz et al. (2012), Moskovic et al. (2012), and Mazolla et al. (2014).41,43–45,57 Despite the overlap between these studies, therapy duration and outcomes differed…”
ResultGuay, A. T., Jacobson, J., Perez, J. B., Hodge, M. B., & Velasquez, E. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900981 · Cited by 128
Restoration of Plasma Testosterone Levels in Uremic Men With Clomiphene Citrate
LIM, V. S., & Fang, V. S. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-6-1370 · Cited by 110
Taylor, F., & Levine, L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01454.x · Cited by 108 · cited 1×
“Taylor and Levine (2010) (n = 103), demonstrated no difference in biochemical outcome of serum TT between CC or usage of testosterone gel.47 Ramasamy et al. (2014) (n = 124) supported this finding between the effect of CC and testosterone gel but found a higher increase of serum TT in patients who…”
ResultThe quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism
Mohamed, O., Freundlich, R. E., Dakik, H. K., Grober, E. D., Najari, B., Lipshultz, L. I., & Khera, M. (2010) · International Journal of Impotence Research · doi:10.1038/ijir.2009.35 · Cited by 103
Helo, S., Ellen, J., Mechlin, C., Feustel, P., Grossman, M., Ditkoff, E., & McCullough, A. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12944 · Cited by 102
Tancredi, A., Reginster, J., Schleich, F., Pire, G., Maassen, P., Luyckx, F., & Legros, J. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510355 · Cited by 102
Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism
Shabsigh, A., Kang, Y., Shabsign, R., Gonzalez, M., Liberson, G., Fisch, H., & Goluboff, E. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00075.x · Cited by 98
The Theoretical and Technical Foundations of Health Measurement
McDowell, I. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195165678.003.0002 · Cited by 87
Ramasamy, R., Scovell, J. M., Kovac, J. R., & Lipshultz, L. I. (2014) · Journal of Urology · doi:10.1016/j.juro.2014.03.089 · Cited by 84
Clomiphene Citrate for the Treatment of Hypogonadism
Wheeler, K. M., Sharma, D., Kavoussi, P. K., Smith, R. P., & Costabile, R. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.10.001 · Cited by 81
Pastuszak, A. W., Gomez, L. P., Scovell, J. M., Khera, M., Lamb, D. J., & Lipshultz, L. I. (2015) · Sexual Medicine · doi:10.1002/sm2.76 · Cited by 71
Complex Genetics in Idiopathic Hypogonadotropic Hypogonadism
Pitteloud, N., Durrani, S., Raivio, T., & Sykiotis, G. P. (2010) · Frontiers of Hormone Research · doi:10.1159/000312700 · Cited by 65
Soares, A. H., Horie, N. C., Chiang, L. A. P., Caramelli, B., Matheus, M. G., Campos, A. H., Marti, L. C., Rocha, F. A., Mancini, M. C., Costa, E. M. F., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0105-2 · Cited by 63
Risk factors for post-treatment hypogonadism in testicular cancer patients.
Eberhard, J., Ståhl, O., Cwikiel, M., Cavallin-Ståhl, E. K., Giwercman, Y. L., Salmonson, E. C., & Giwercman, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0684 · Cited by 60
Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism
Krzastek, S. C., Sharma, D., Abdullah, N., Sultan, M., Machen, G. L., Wenzel, J. L., Ells, A., Chen, X., Kavoussi, M., Costabile, R. A., et al. (2019) · Journal of Urology · doi:10.1097/ju.0000000000000396 · Cited by 52
Habous, M., Giona, S., Tealab, A., Aziz, M., Williamson, B., Nassar, M., Abdelrahman, Z., Remeah, A., Abdelkader, M., Binsaleh, S., et al. (2018) · BJU International · doi:10.1111/bju.14401 · Cited by 51
Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism
Mazzola, C. R., Katz, D. J., Loghmanieh, N., Nelson, C. J., & Mulhall, J. P. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12592 · Cited by 50 · cited 8×
“Another gap in current knowledge is what predictors are influencing the response on CC. Mazzola et al. (2014) (n = 76) stated that a low LH and greater testicular volume predict a better CC response.43 Guay et al. (2003) (n= 178) described age and the presence of diabetes as predictors for the response to CC.”
BackgroundInfluentialAzoospermia after treatment with clomiphene citrate in patients with oligospermia
Pasqualotto, F. F., Fonseca, G. P., & Pasqualotto, E. B. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.036 · Cited by 48
Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.10.001 · Cited by 48
Wheeler, K. M., Smith, R. P., Kumar, R. A., Setia, S., Costabile, R. A., & Kavoussi, P. K. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.068 · Cited by 47
Wiehle, R. D., Cunningham, G. R., Pitteloud, N., Wike, J., Hsu, K., Fontenot, G. K., Rosner, M. H., Dwyer, A. A., & Podolski, J. S. (2013) · British Journal of Urology · doi:10.1111/bju.12363 · Cited by 46
An update on male hypogonadism therapy
Surampudi, P., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 45
(2000) · Springer eBooks · doi:10.1007/978-3-662-05739-1 · Cited by 42
The safety and efficacy of clomiphene citrate in hypoandrogenic and subfertile men
Patel, D. P., Brant, W. O., Myers, J. B., Presson, A. P., Johnstone, E. B., Dorais, J., Aston, K. I., Carrell, D. T., & Hotaling, J. M. (2015) · International Journal of Impotence Research · doi:10.1038/ijir.2015.21 · Cited by 40
Da Ros, C. T., & Averbeck, M. A. (2012) · International braz j urol · doi:10.1590/s1677-55382012000400011 · Cited by 39
Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
Dadhich, P., Ramasamy, R., Scovell, J. M., Wilken, N., & Lipshultz, L. I. (2017) · Indian Journal of Urology · doi:10.4103/iju.iju_372_16 · Cited by 37
Enclomiphene citrate for the treatment of secondary male hypogonadism
Rodríguez, K. M. G., Pastuszak, A. W., & Lipshultz, L. I. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1204294 · Cited by 36
Male prolactinomas presenting with normal testosterone levels
Shimon, I., & Benbassat, C. A. (2013) · Pituitary · doi:10.1007/s11102-013-0497-x · Cited by 34
Possible hypothalamic impotencemale counterpart to hypothalamic amenorrhea?
Guay, A. T., Bansal, S., & Hodge, M. B. (1991) · Urology · doi:10.1016/0090-4295(91)80143-u · Cited by 30
Treatment of hypogonadotropic male hypogonadism: Case-based scenarios
Crosnoe-Shipley, L., Elkelany, O. O., Rahnema, C. D., & Kim, E. D. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i2.245 · Cited by 29
Systematic review of hormone replacement therapy in the infertile man
Meliegy, A. E., Motawi, A. T., & Salam, M. A. A. E. (2018) · Arab Journal of Urology · doi:10.1016/j.aju.2017.11.011 · Cited by 29
Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men
Bendre, S. V., Murray, P. J., & Basaria, S. S. (2015) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000155 · Cited by 26
Selective androgen receptor modulators for the treatment of late onset male hypogonadism
Dalton, J. T., Coss, C. C., Jones, A., Hancock, M., & Steiner, M. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122339 · Cited by 24
EAU-Leitlinie Männlicher Hypogonadismus
Dohle, G. R., Arver, S., Bettocchi, C., Jones, T. H., & Kliesch, S. (2018) · Journal für Reproduktionsmedizin und Endokrinologie · Cited by 22
Ribeiro, R. S., & Abucham, J. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000400005 · Cited by 19
Clomiphene citrate improved testosterone and sperm concentration in hypogonadal males
Delu, A., Kiltz, R. J., Kuznetsov, V. A., & Trussell, J. C. (2020) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2020.1822457 · Cited by 18
Liel, Y. (2016) · Endocrine Practice · doi:10.4158/ep161543.or · Cited by 14
Keihani, S., Wright, L. N., Alder, N. J., Jiang, J., Cheng, P. J., Stoddard, G. J., Pastuszak, A. W., Deibert, C. M., & Hotaling, J. M. (2020) · Urology · doi:10.1016/j.urology.2020.04.074 · Cited by 13
Clomiphene citrate treatment for late onset hypogonadism: rise and fall
Marconi, M., Souper, R., Hartmann, J., Alvarez, M., Fuentes, I., & Guarda, F. J. (2016) · International braz j urol · doi:10.1590/s1677-5538.ibju.2016.0112 · Cited by 11
Clomiphene citrate therapy for male infertility
Allag, I. S., & Alexander, N. J. (1979) · Urology · doi:10.1016/0090-4295(79)90184-5 · Cited by 9
Hipogonadismo hipogonadotropo funcional hipotalámico idiopático pospuberal en el varón
Canessa, E. D., & Cerda, M. L. A. (2008) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(08)75676-0 · Cited by 5
MP58-05 A NOMOGRAM PREDICTING TESTOSTERONE RESPONSE IN MEN ON CLOMIPHENE
Salter, C. A., Zajichek, A., Benfante, N. E., Kattan, M. W., & Mulhall, J. P. (2019) · The Journal of Urology · doi:10.1097/01.ju.0000556697.01769.d2 · Cited by 4
Tan, J.-S., Chang, H.-C., Chung, S., Chen, P.-H., & Wu, W.-C. (2016) · Urological Science · doi:10.1016/j.urols.2016.03.001 · Cited by 3
Clinical effects assessment of clomiphene on young man hypogonadism patients for adjuvant therapy
Zhu, X., Huang, H., Huang, Y., & Fu, D. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-938 · Cited by 1
Research works printed but not linked: 4
- Dohle G, 2015, Guidelines on male hypogonadism, Eur Assoc Urol
- Review Manager (RevMan). Version 5.4. The Cochrane Collaboration;2020.
- Guay A, 1995, Effect of raising endogenous testosterone impotent, J Clin Endocrinol Metab, 80, 3546
- Dohle GR, 2018, European Association of Urology (EAU) guidelines on male hypogonadism, Journal of Reproductive Medicine and Endocrinology
Cited by
Reproductive axis ageing and fertility in men
da Silva, S. M., & Anderson, R. A. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09759-0 · Cited by 83
Grant, B., Kean, J., Vali, N., Campbell, J., Maden, L., Bijral, P., Dhillo, W. S., McVeigh, J., Quinton, R., & Jayasena, C. N. (2023) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-023-00573-8 · Cited by 55
Androgen abuse: Risks and adverse effects in men
Grant, B., Hyams, E., Davies, R., Minhas, S., & Jayasena, C. N. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15187 · Cited by 48
Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
Fink, J. E., Ide, H., & Horie, S. (2024) · Medicina · doi:10.3390/medicina60020275 · Cited by 33
Grant, B., Campbell, J., Pradeep, A., Burns, A., Bassett, P., Abbara, A., Saket, P., Minhas, S., Dhillo, W. S., McVeigh, J., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad164 · Cited by 24
Metadata
- Authors
- Huijben, M., Lock, M. T. W. T., de Kemp, V. F., de Kort, L. M. O., & van Breda, H. M. K.
- Affiliations
- University Medical Center Utrecht (NL)
- Department of Urology University Medical Centre Utrecht Utrecht The Netherlands
- Corresponding author
- Huijben, Manou
- Venue
- Andrology
- Publisher
- Wiley
- Published
- 2022-01-08
- Volume
- 10
- Issue
- 3
- Pages
- 451-469
- ISSN
- 2047-2919 (ISSN-L)
- 2047-2927
- OpenAlex
- W4200411621
- Semantic Scholar
- d139798b0eb7fa3286fbb84aa6af1669a0f17824
- Cited by
- 65
- References
- 68
- Citations by year
- 2026: 15 · 2025: 9 · 2024: 15 · 2023: 15 · 2022: 11
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- Locations
- Andrology (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- clomiphene citrate, male hypogonadism, androgen deficiency, testosterone, free testosterone, luteinizing hormone, follicle-stimulating hormone, sex hormone-binding globulin, estradiol, off-label therapy, adverse effects, lipid profile
- MeSH terms
- Clomiphene, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.